aamc.org does not support this web browser.

Washington Highlights

Washington Highlights is a weekly newsletter that provides updates on the latest legislative and regulatory activities affecting medical schools, teaching hospitals, and their patients and communities.

Recent Articles

""
Washington Highlights

The AAMC joined a Sept. 30 group letter urging lawmakers to oppose an NDAA provision limiting animal research.

  • Oct. 4, 2024
A researcher in a lab scans lab equipment
Washington Highlights

The AAMC on Sept. 26 responded to the FDA’s draft guidance on Diversity Action Plans to improve enrollment in clinical trials.

  • Oct. 4, 2024
A group of diverse women medical providers with masks
Washington Highlights

The AAMC submitted comments Oct. 4 to the HHS ASTP/ONC’s second Health Data, Technology, and Interoperability (HTI) proposed rule.

  • Oct. 4, 2024
Doctors in a meeting at hospital
Washington Highlights

After HRSA sent a second letter threatening enforcement action, Johnson & Johnson withdrew its proposed rebate model for two 340B drugs.

  • Oct. 4, 2024
Blurred shot of doctors working in a busy hospital corridor
Washington Highlights

In an interim final rule on the FY 2025 Inpatient Prospective Payment System, the CMS withdrew its low wage index policy for fiscal year 2025.

  • Oct. 4, 2024
pill bottles
Washington Highlights

The CMS finalized a rule related to the Medicaid Drug Rebate Program, which includes changes to the definition of covered outpatient drug.

  • Sept. 27, 2024

Other Washington Highlights Articles

91-aamc-news-gun-violence-hero.jpg__992x558_q85_crop-smart_subsampling-2_upscale
Washington Highlights

The White House announced Sept. 26 executive actions through several federal agencies intended to enhance gun violence prevention.

  • Sept. 27, 2024
Healthcare workers meeting
Washington Highlights

President Joe Biden on Sept. 26 signed a continuing resolution to fund the government through Dec. 20.

  • Sept. 27, 2024
Two researchers wearing lab coats and eye protection analyze a sample in a laboratory.
Washington Highlights

The Senate Homeland Security and Governmental Affairs Committee advanced the Risky Research Review Act along a bipartisan vote.

  • Sept. 27, 2024
Rotunda_1200x666

Scheduled hearings and meetings related to academic medicine.

Read On the Agenda In Washington

testimony and correspondence graphic

Find congressional testimony, letters to Capitol Hill and federal agencies, and comment letters on policy issues.

Read Testimony and Correspondence

Contact the AAMC Office of Government Affairs Staff

Email Us